Literature DB >> 9498629

Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy.

T Fujisawa1, H Ikegami, Y Kawaguchi, Y Hamada, H Ueda, M Shintani, M Fukuda, T Ogihara.   

Abstract

An insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme (ACE) gene has repeatedly been shown to be associated with ischaemic heart disease, but the association of this genetic marker with diabetic microangiopathy is controversial. To assess the association of the genotypes with the development of diabetic nephropathy or retinopathy, we performed a meta-analysis of data from the literature, using Mantel-Haenszel method followed by the Breslow-Day test for assessing homogeneity among data. In a total of 4773 diabetic patients from 18 studies with (n = 2495) and without (n = 2278) renal complications, the D allele was significantly associated with diabetic nephropathy (p < 0.0001) in a dominant model (summary odds ratio 1.32, 95% confidence interval: 1.15 to 1.51). There was no significant evidence against homogeneity of the odds ratios (chi(2) = 18.9, 20 df; p = 0.53). The association was significant both in non-insulin-dependent (p < 0.005) and in insulin-dependent diabetes mellitus (p < 0.05). Likewise, in a total of 2010 diabetic patients with (n = 1008) and without (n = 1002) retinopathy, there was no association of the I/D polymorphism with diabetic retinopathy. These data suggest that the ACE I/D polymorphism affects the risk for diabetic nephropathy, but not for diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498629     DOI: 10.1007/s001250050865

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

Review 1.  Role of ACE inhibitors in patients with diabetes mellitus.

Authors:  D J Cordonnier; P Zaoui; S Halimi
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Does familial clustering of risk factors for long-term diabetic complications leave any place for genes that act independently?

Authors:  Andrew D Paterson; Shelley B Bull
Journal:  J Cardiovasc Transl Res       Date:  2012-06-23       Impact factor: 4.132

3.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

4.  Genetic polymorphism of DNA methyltransferase 3B 149 C>T and risk of colorectal cancer: a meta-analysis.

Authors:  Qingkai Meng; Jingru Zhang; Bo Lian; Chun Song
Journal:  Tumour Biol       Date:  2013-11-01

5.  ACE gene insertion/deletion polymorphism in childhood idiopathic nephrotic syndrome.

Authors:  Erkin Serdaroglu; Sevgi Mir; Afig Berdeli; Nejat Aksu; Mustafa Bak
Journal:  Pediatr Nephrol       Date:  2005-10-06       Impact factor: 3.714

Review 6.  Risk predictors in patients with diabetic nephropathy.

Authors:  P Fioretto; M L Caramori; M Dalla Vestra; M Mauer
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 7.  Genetics of diabetes complications.

Authors:  Donald W Bowden
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

8.  The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis.

Authors:  Li Xiao; Ming Tong; Yanyang Jin; Weichao Huang; Zizhi Li
Journal:  Mol Biol Rep       Date:  2012-10-21       Impact factor: 2.316

9.  Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients.

Authors:  Hyeong Cheon Park; So Rae Choi; Beom Seok Kim; Tae Hee Lee; Byung Seung Kang; Kyu Hyun Choi; Ho Yung Lee; Dae Suk Han; Sung-Kyu Ha
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

10.  Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects.

Authors:  Jaime J Jayapalan; Sekaran Muniandy; Siew P Chan
Journal:  Indian J Hum Genet       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.